l-3,4-Dihydroxyphenylalanine (l-DOPA), a precursor of dopamine (DA), replenishes disease-related lower levels of DA by conversion of l-DOPA to DA in the brain by aromatic l-amino acid decarboxylase (AADC) and alleviates motor symptoms of PD. Here, DDC is linked to Parkinson disease.